Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Advances in Skin Immune-Mediated Disease"
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Clinical Immunology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 8962
Special Issue Editors
Interests: psoriasis; psoriatic arthritis; atopic dermatitis; immunopharmacology; skin biology; skin immune system; skin and internal diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue in Vaccines: Feature Papers of Clinical Immunology
Special Issue in Vaccines: Role of Inflammasome Activation in Atherosclerosis
Special Issue in Journal of Clinical Medicine: Ethnic Differences in Dermatitis and Atopic Eczema and Its Management
2. Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy
Interests: skin immunology; inflammatory skin disorders; psoriasis; atopic dermatitis
Special Issue Information
The advances in the understanding of pathophysiology in immune-mediated disease enhanced the capability in identifying new therapeutic targets or novel therapeutic strategies. Common inflammatory skin disorders including psoriasis and atopic dermatitis had significant benefits from the intense research on immune mechanisms involved in their pathogenesis. Indeed, an expanded therapeutic armamentarium of selective agents blocking soluble cytokines, cytokine receptors, or intracellular signal transducers was developed providing multiple therapeutic agents having different targets. For other skin diseases with a critical immune component a new era for their therapeutic management is approaching or has been barely started. This special issue aims to collect recent findings on the identification of therapeutic targets and the development of immune-targeted therapies for the treatment of immune-mediated skin conditions, including psoriasis, atopic dermatitis, lichen planus, alopecia areata, bullous diseases, lupus, and scleroderma. We are hopeful that this special issue with a focus on the role of inflammation in skin disease and the therapeutic relevance of targeting immune mediators, will serve as a valuable tool in expanding the reader's knowledge on the complexity of certain skin diseases and the significant role played by the immune system.
Prof. Dr. Giampiero Girolomoni
Dr. Andrea Chiricozzi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.